Search Results - "Pantani L"

Simplified optical correlator for radar-signal processing.

Authors: Atzeni, C. Pantani, L.

Source: Proceedings of the IEEE; March 1969, Vol. 57, p344-346, 3p

Some experimental confirmations of the simplified optical-correlator theory.

Authors: Pantani, L.

Source: Proceedings of the IEEE; June 1972, Vol. 60, p750-751, 2p

Optical signal-processing through dual-channel ultrasonic light modulators.

Authors: Atzeni, C. Pantani, L.

Source: Proceedings of the IEEE; March 1970, Vol. 58, p501-502, 2p

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Authors: Cavo M Tacchetti P Patriarca F et al.

Source: Lancet. 12/18/2010, Vol. 376 Issue 9758, p2075-2085. 11p.

Some experimental confirmations of the simplified optical-correlator theory.

Authors: Pantani, L.

Source: Proceedings of the IEEE; February 1973, Vol. 61, p251-251, 1p

Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real‐World Evidence in a Rapidly Evolving Therapeutic Landscape.

Authors: Mancuso, K. Masci, S. Talarico, M. et al.

Source: European Journal of Haematology. Jun2026, Vol. 116 Issue 6, p928-936. 9p.

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.

Authors: Puppi, M. Sacchetti, I. Mancuso, K. et al.

Source: Mediterranean Journal of Hematology & Infectious Diseases. 2025, Vol. 17, p1-17. 17p.

Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study.

Authors: Mancuso, K. Mina, R. Rocchi, S. et al.

Source: Cancer Medicine. Nov2024, Vol. 13 Issue 22, p1-12. 12p.

A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.

Authors: Rizzello, I. Sacchetti, I. Barbato, S. et al.

Source: Clinical & Experimental Medicine. 11/25/2025, Vol. 26 Issue 1, p1-13. 13p.

Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?

Authors: Talarico, M. Barbato, S. Maisnar, V. et al.

Source: Journal of Cancer Research & Clinical Oncology. Nov2025, Vol. 151 Issue 11, p1-10. 10p.

Fluorescence lidar imaging of the cathedral and baptistery of Parma.

Authors: Lognoli, D. Cecchi, G. Mochi, I. et al.

Source: Applied Physics B: Lasers & Optics. 2003, Vol. 76 Issue 4, p457. 9p.

Monitoring of volcanic sulphur dioxide emissions using differential absorption lidar (DIAL), differential optical absorption spectroscopy (DOAS), and correlation spectroscopy (COSPEC).

Authors: Weibring, P. Edner, H. Svanberg, S. et al.

Source: Applied Physics B: Lasers & Optics. 1998, Vol. 67 Issue 4, p419. 8p.

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease.

Authors: Brioli, A Zamagni, E Pasquali, S et al.

Source: Bone Marrow Transplantation. Sep2012, Vol. 47 Issue 9, p1248-1249. 2p. 1 Chart.

Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.

Authors: Talarico M Vischini G Barbato S et al.

Source: Frontiers in oncology [Front Oncol] 2025 Oct 07; Vol. 15, pp. 1672690. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.

Authors: Bigi F Fiacchini M Restuccia R et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2025 May 27; Vol. 25 (1), pp. 179. Date of Electronic Publication: 2025 May 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.

Authors: Martello M Solli V Mazzocchetti G et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Nov 28; Vol. 14 (1), pp. 208. Date of Electronic Publication: 2024 Nov 28.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.

Authors: Tacchetti P Talarico M Barbato S et al.

Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Jun; Vol. 24 (6), pp. 379-395. Date of Electronic Publication: 2024 May 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma.

Authors: Poletti A Taurisano B Mazzocchetti G et al.

Source: Haematologica [Haematologica] 2025 Oct 01; Vol. 110 (10), pp. 2436-2450. Date of Electronic Publication: 2025 May 15.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.

Authors: Terragna C Poletti A Solli V et al.

Source: Nature communications [Nat Commun] 2024 Feb 20; Vol. 15 (1), pp. 1551. Date of Electronic Publication: 2024 Feb 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.

Authors: Borsi E Mazzocchetti G Dico AF et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2023 Dec; Vol. 23 (8), pp. 5227-5239. Date of Electronic Publication: 2023 Oct 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE